BNFC.org

BNF for Children

BNF for Children: ENTER

Contact Us

If you are having problems registering to use this website please refer to the Frequenly Asked Questions about Registration

For enquiries on any of the topics listed below please follow the link for more information:

Enquiries about the clinical content of the BNF for Children

The BNFC is constructed to support healthcare professionals in making decisions about effective and safe use of medicines. The editors welcome comments that help to improve the information that the BNFC provides. Occasionally, where the BNFC's advice is felt to be ambiguous, the editors will be pleased to provide the necessary clarification to individual healthcare professionals and organisations who use BNFC data under the terms of an agreement with us. We are however concerned that increasingly our editorial resources are being diverted to provide background information to other information providers. This extra workload is not sustainable and we have therefore drawn up a list of dos and don'ts regarding information requests to the BNFC:

Do

  • Tell us if you believe the BNFC advice is misleading or inaccurate. We would particularly like to understand why you consider the advice deficient and it would therefore be useful to receive evidence that supports your view

  • Relate the enquiry to the specific scenario encountered. This again helps us to understand the context of your enquiry better.

  • Take into account that the BNFC is constructed for non-specialists and it cannot always include information to support specialist or expert practice

  • Give us time to look into the enquiry. The BNFC is not geared to provide immediate response - editors may need to look through a great deal of documentation and retrieve previous notes in order to address specific issues. Enquirers also need to bear in mind that during certain periods of the editorial cycle, it may not be possible to devote the necessary time to research into the enquiries

  • Tell us which reference sources you have already looked at

  • Look at the pages on this website that explain how the BNFC is constructed and also check if the BNFC's responses to frequently asked questions deal with the enquiry

Don't
  • Contact us without checking the information yourself. This means that enquirers should have checked in the relevant current summary of product characteristics and other sources in common use
  • Expect the BNFC to provide copies of background papers or lists of references. Enquirers should refer to recent clinical reviews for such information. The BNFC cannot conduct literature searches for enquirers.
  • Ask the BNFC to provide information on areas that are outside the scope of the BNFC (e.g. foreign medicines)
  • Expect the BNFC to make a comment on individual treatment; these matters are best addressed by clinicians who have the necessary training and are familiar with the case details

The BNFC staff are not permitted to correspond with patients or their relatives about individual treatments.

Bearing in mind the guidance above, if you have an enquiry about the publication's clinical content, please contact:

bnfc@bnf.org

Manufacturers wishing to inform us of new products and changes to existing products

To allow time for editorial processes, we have cut-off dates for receiving information for each edition. For a new product to be considered for inclusion in the next edition of the BNF or BNF for Children, all relevant information needs to be supplied before the cut-off deadline.

Information about changes to existing products (e.g. updated SPCs, “Dear Healthcare Professional” letters etc) also needs to reach us by the cut-off deadline to allow time for consideration by the editors.

Please contact us at

editor@bnf.org
for the next cut-off deadline.

Please note that due to an increasing volume of information from manufacturers immediately before cut-off time, this date is a guide only. We encourage you to submit your completed information to us as early as possible.

To consider listing new products, we will initially require the following details:

  • Copy of the latest full SPC (approved version with a date of approval, not a draft version) or datacard;
  • Launch date;
  • Basic NHS price of all available pack sizes;
  • Detailed description of dosage form (colour, tablets scored etc) if not on SPC;
  • Prescribing status - is it prescription-only medicine (POM), Pharmacy (P), General Sales List (GSL) item, or a medical device?
  • Is the item marketed directly to consumers?
  • NHS status - is the item reimbursable through the NHS scheme?
  • Black triangle status (subject to CHM intensive post-marketing surveillance?)
  • Confirmation of which company will be providing medical information for the product to clinicians in the UK (postal address, medicines information telephone number and email address)

Please send all information to

editor@bnf.org

The editors will consider the information provided, and decide if an entry in the BNF is appropriate. We will contact you if further information is required. We cannot guarantee that any new product or information will be included in the forthcoming edition. Please note that the BNF cannot advise if a new product or new information will be included in an edition until after it has been published.

Privacy policy

For information about our Privacy policy please contact:

cmacfarlane@bnf.org

Links to and from the BNFC website

If you wish to link to a page of our website other than the homepage please contact:

cmacfarlane@bnf.org

Copyright permissions

If you wish to reproduce an extract from this website that goes beyond what we permit in our Permissions and Licensing policy please contact:

monika.buczynska@rpsgb.org

Licensing

If you would like more information about licensing digital BNFC material please contact:

electronicinfo@rpsgb.org

Reporting faulty printed BNFCs

If you receive a faulty printed BNFC, please contact John Wilson at the Pharmaceutical Press:

john.wilson@rpsgb.org

Distribution of printed BNFCs

The UK health departments distribute BNFCs to NHS hospitals, doctors, surgeons, and community pharmacies. In England, BNFCs are mailed individually to NHS general practitioners and community pharmacies; contact the DH Publication Orderline on 0300 123 1003 for extra copies or changes relating to mailed BNFCs. In Wales, telephone the Business Services Centre on 01495 332 000.

Other enquiries

For all other enquiries about this website, its content or the policies pertaining to it please contact:

webmaster@bnf.org
 

BNF EXTRA

Copyright © BMJ Group, RPS Publishing, and RCPCH Publications Ltd 2009. All rights reserved.